Reid D'Amico, Ph.D., serves as Principal and Lead of Regulatory Science and Strategy at IQVIA since January 2022, having previously held the position of Associate Principal. Prior experience includes Specialist Master at Deloitte from May 2019 to January 2022, focusing on scientific and regulatory management, and a Fellowship at the FDA from August 2018 to December 2021 within the Oncology Center of Excellence and Center for Devices. Reid has also worked as a Postmarket Solutions Consultant at Allergan and as a Trial Design Consultant at SPYRYX Biosciences. Academic achievements include a Doctor of Philosophy in Bioengineering and Biomedical Engineering from Vanderbilt University and a Bachelor's Degree in the same field from Duke University.